Pharmaceuticals News and Research

RSS

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognized with one of SCI Scotland’s most prestigious honors – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research.

16 Jan 2019

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

From Charles River 16 Jan 2019

Meth’s resurgence spotlights lack of meds to combat the addiction

In 2016, news reports warned the public of an opioid epidemic gripping the nation. But Madeline Vaughn, then a lead clinical intake coordinator at the Houston-based addiction treatment organization Council on Recovery, sensed something different was going on with the patients she checked in from the street.

14 Jan 2019

Emergency medical responders confront racial bias

A recent study out of Oregon suggests emergency medical responders — EMTs and paramedics — may be treating minority patients differently from the way they treat white patients.

11 Jan 2019

Researchers employ machine learning to uncover new insights into human brain's cellular architecture

An inter-disciplinary research team led by scientists from the National University of Singapore has successfully employed machine learning to uncover new insights into the cellular architecture of the human brain.

10 Jan 2019

Drug development options diversified with new manganese catalyst

A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

9 Jan 2019

FDA approves initiation of first-in-human trial of DNA-encoded monoclonal antibody

The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.

9 Jan 2019

Essential nutrient may hold promise in the war against Alzheimer's disease

In a new study, researchers at the Biodesign Institute explore a safe and simple treatment for one of the most devastating and perplexing afflictions: Alzheimer's disease.

8 Jan 2019

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Hoping to earn its share of the $3.5 trillion health care market, the medical industry is pouring more money than ever into advertising its products — from high-priced prescriptions to do-it-yourself genetic tests and unapproved stem cell treatments.

8 Jan 2019

Researchers design new questionnaire to improve knowledge of impact of menopause on women

A new questionnaire being developed through a collaboration between the Massachusetts General Hospital Midlife Women's Health Center and the North American Menopause Society is designed to improve knowledge of the extent and impact on women of genitourinary symptoms of menopause.

8 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Podcast: KHN’s ‘What the Health?’ Ask us anything!

This week, KHN's "What the Health?" panelists answered questions submitted by listeners.

3 Jan 2019

New review focuses on the structure-activity relationships of flavonoids

ABCB1 in the ABC transporter family also termed as P-glycoprotein, grants the simultaneous resistance of metastatic cancer cells towards various anti-cancer drugs with different targets and diverse chemical structures.

27 Dec 2018

Statins reduce the formation of brown adipose tissue

A certain proportion of the adult population has not only white adipose (or fatty) tissue, but also the brown kind. This brown adipose tissue helps to convert sugar and fat into heat. People with brown adipose tissue are better at regulating their body temperature in the winter, and are less likely to suffer from excess weight or diabetes.

21 Dec 2018

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

21 Dec 2018

AHF urges the WHO to expedite approval process for vaccine effective against Ebola

With the world's second worst Ebola outbreak in history recently spreading to a major city in the Democratic Republic of the Congo, the World Health Organization and Merck must do more to ensure all options are on the table to fight the virus, including ensuring vaccines are available to all who need them.

17 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Pharmaceuticals News and Research

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Meth’s resurgence spotlights lack of meds to combat the addiction

Emergency medical responders confront racial bias

Researchers employ machine learning to uncover new insights into human brain's cellular architecture

Drug development options diversified with new manganese catalyst

FDA approves initiation of first-in-human trial of DNA-encoded monoclonal antibody

Essential nutrient may hold promise in the war against Alzheimer's disease

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Researchers design new questionnaire to improve knowledge of impact of menopause on women

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Podcast: KHN’s ‘What the Health?’ Ask us anything!

New review focuses on the structure-activity relationships of flavonoids

Statins reduce the formation of brown adipose tissue

New treatment for adults with rare, life-threatening blood disease receives FDA approval

AHF urges the WHO to expedite approval process for vaccine effective against Ebola

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Nurse denied life insurance because she carries naloxone

For the asking, a check is in the mail to help pay for costly drugs

UAlberta scientists identify biomarkers for detecting Alzheimer's disease in saliva samples

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring